While each day brings fresh updates on the progress of companies developing vaccines to fight COVID-19, which are rightly seen as the most powerful weapon against the novel coronavirus, the potential of novel antibody cocktails is also being explored at pace by biopharma companies, government and academic researchers.
The promise is that a mix of two or more antibodies, either discovered in the lab or based on antibodies...







![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)